HyperSpectral Raises $7M in Oversubscribed Series A-2 Round to Accelerate Growth
October 7, 2025
Company Welcomes Dr. Chuck Mattera, former Chair and CEO of Coherent Corp as new Chairman ALEXANDRIA, VA – HyperSpectral, the world’s first AI-powered spectral intelligence company, today announced the close of a $7M Series A-2 capital raise. The round will fuel accelerated development, expand partnerships, and position the company for a Series B round in [...]
Nanalysis announces support from Wiley for NMR Instruments in KnowItAll 2026
October 7, 2025
CALGARY, AB - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable Nuclear Magnetic Resonance (NMR) instruments and Magnetic Resonance Imaging (MRI) technology for industrial and research applications, announced new file support from Wiley, a global leader in authoritative content and research intelligence, in their KnowItAll 2026 software release [...]
Wiley announces support for Nanalysis NMR instruments in KnowItAll 2026
October 7, 2025
Nanalysis 1D NMR files can now be imported into KnowItAll 2026 providing access to over 1.28 million NMR spectra for database searching.* Wiley, a global leader in authoritative content and research intelligence, announced new file support in their KnowItAll 2026 software release for raw NMR files from Nanalysis, a leader in benchtop NMR spectrometers and [...]
October 7, 2025
Countable 10 is the first PCR platform to analyze 10 distinct fluorophores in the same reaction Giovanna Prout joins Countable Labs as CEO to accelerate commercialization of Countable Labs’ products PALO ALTO, Calif.--Countable Labs, the developer of Countable PCR, a category-defining PCR technology that sets a new benchmark for sensitivity in genomics, announced the launch [...]
October 7, 2025
DURHAM, N.C. -- BioSkryb Genomics, a pioneer in single-cell and ultra–low-input multiomic solutions, together with Eremid® Genomic Services, a specialty high-complexity genomics contract research organization and BioSkryb Certified Service Provider (CSP), today announced the launch of an Early Access Program for BioSkryb’s new ResolveSEQ LongRead solution. Through this program, researchers will gain access to services [...]
October 7, 2025
FREDERICK, Md. and PLANO, Texas -- RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development services, and Secretome Therapeutics, a clinic-stage company developing novel therapies derived from neonatal cardiac progenitor cells (nCPC), today announced completion of commercial scale production of Secretome's lead nCPC, STM-01. In March 2025, [...]
October 7, 2025
LINCOLN, Neb. -- LI-COR announces the launch of the AtmospherIQ™ Gas Analyzers, a new generation of instruments designed for exceptional accuracy, long-term stability, and ease of use. Built to meet the growing need for reliable atmospheric monitoring, AtmospherIQ Gas Analyzers provide world-class performance at lower cost, offering a breakthrough in scalability for expanding city, regional, [...]
Golden Helix Receives a NIH SBIR Phase 2 Grant
October 7, 2025
Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options BOZEMAN, Mont. -- Golden Helix, Inc. announced that it was awarded the NIH SBIR Grant 2R44HG013456-02 "Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options." Pharmacogenomics is expanding clinicians' ability to deliver personalized medicine, enabling drug selection, dosage, efficacy, and safety to be tailored to each patient's unique biological needs. [...]
October 7, 2025
The first command center for scientific AI, bringing agents and models to every scientist SAN FRANCISCO -- Benchling AI launches today, giving scientists a command center to access AI directly in the platform they trust. At a time where AI is transforming every industry, Benchling is bringing agents and predictive models into the scientific workflow, [...]
Cytiva receives ARPA-H award with ambition to help transform CAR-T cell therapy for solid tumors
October 7, 2025
Anticipated collaboration with leading academic institutions aims to overcome key barriers in cell and gene therapy by targeting solid tumors, enabling in vivo treatment, and radically reducing manufacturing costs Cytiva (Global Life Sciences Solutions USA, LLC), a Danaher company and a global leader in the life sciences industry, will lead a new effort aiming to [...]

